Cooperative Agreement 72066323CA00007

This $589,000 Project Grant was awarded by the U.S. Department of State's Bureau of African Affairs under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program (CFDA 19.029). The purpose of this grant is to contribute to ensuring access to and quality of HIV services, including protecting the human rights of people infected and affected by HIV, through community-led monitoring (CLM) activities led by affected and infected community members in Ethiopia. The grant recipient, Tamra...

This $287,878,180 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program is intended to scale up and improve management of drug-resistant tuberculosis (DR-TB) in USAID-supported countries. The award, which has an ultimate completion date of September 30, 2029, will focus on expanding access to high-quality DR-TB treatment services and providing specialized technical assistance...

The U.S. Agency for International Development (USAID) has awarded a 5-year, $7.9 million Cooperative Agreement under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program. The purpose of this activity is to support the strengthening of Tanzania's capacities to develop, validate, and implement interventions to prevent, detect, and respond to emerging infectious diseases. The award was made to the Center for International Health, Education and Biosecurity-Tanzania, a...

The $3,595,735 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program aims to reduce the burden of tuberculosis (TB), particularly drug-resistant TB, in the Central Asia region within five years. The award, granted to the Dutch non-profit organization Koninklijke Nederlandse Centrale Vereniging Tot Bestrijding DER Tuberculose (Kncv), will support technical expertise,...

The U.S. Agency for International Development (USAID) awarded a $6,925,000 Cooperative Agreement under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program to University Research Co., LLC to implement the "TB-FREE LUZON ACTIVITY" in the Philippines. The five-year project, with a start date of September 26, 2024 and a completion date of September 25, 2029, aims to strengthen tuberculosis (TB) prevention and control services in the Luzon region of the Philippines....

The U.S. Agency for International Development (USAID) awarded a $4,650,276 Cooperative Agreement under the Foreign Assistance for Programs Overseas (CFDA 98.001) grant program to JSI Research & Training Institute Inc., a non-profit organization, to implement the "CURE TUBERCULOSIS PROJECT 2" in Kyrgyzstan. The 5-year project aims to reduce the tuberculosis (TB) burden and establish a sustainable and responsive TB care system, with a focus on early screening, diagnosis, personalized...

This Cooperative Agreement award, valued at $4,003,313.00, was issued by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) grant program. The purpose of this 5-year award, running from October 2024 to September 2029, is to increase access to and sustainability of quality tuberculosis (TB) diagnosis, treatment, and prevention services in Cambodia through three key objectives: 1) Effective linkages to the healthcare system,...

This $7,000,000 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program supports actions to fight tuberculosis (TB) in the Philippines over a 5-year period from October 2024 to September 2029. The project, titled "ACTIONS TO SUPPORT WIDE-SCALE INTERVENTIONS TO FIGHT TB IN THE PHILIPPINES (ACT SWIFT)", will be implemented by the Philippine Tuberculosis Society, Inc. This award...

This $2,500,000 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance Program (CFDA 98.001) aims to improve the tuberculosis (TB) epidemic response in the high-burden northern and central provinces of Mozambique. The award, effective from July 12, 2024 to July 11, 2029, will be implemented by the Center for Collaboration in Health, a non-profit non-governmental organization based in Maputo, Mozambique. The project seeks to...

The Cooperative Agreement award titled "TUBERCULOSIS-FREE VISAYAS AND MINDANAO" is funded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program. The $6,480,574 award, made on January 6, 2025, supports a 5-year project by the Tropical Disease Foundation Inc. (TDF), a non-profit organization based in the Philippines, to control and prevent the spread of tuberculosis in the Visayas and Mindanao regions of...